Dr. Soliman Abdel Kader Fakeeh Hospital Company announces an update about the Share Purchase Agreement to acquire 100% of Dr. Mohammed Bin Rashid Al Fagih & Partners Company by the issuance of the non-objection of the General Authority for Competition.

Element List	Explanation
Introduction	With reference to the announcement made by Dr. Soliman Abdel Kader Fakeeh Hospital Company (the “Company”), which was published on the Saudi Stock Exchange's (Tadawul) website on 19/11/1447H (corresponding to 06/05/2026G) in respect of the signing of a binding Share Purchase Agreement (the “Agreement”) with all shareholders of Dr. Mohammed Bin Rashid Al Fagih & Partners Company (the “Target Company”) to acquire 100% of its share capital in exchange for a total cash amount of SAR 1,595,625,000 (the “Transaction”). The Company wishes to announce that the General Authority for Competition has issued a non-objection regarding the economic concentration resulting from the Transaction on 11/06/2026G (corresponding to 25/12/1447H). The Company notes that the Transaction remains subject to a number of other conditions.
Previous Announcement	Dr. Soliman Abdel Kader Fakeeh Hospital Company announces the signing of a binding Share Purchase Agreement to acquire 100% of Dr. Mohammed Bin Rashid Al Fagih & Partners Company (the “Target Company”).
Date of Previous Announcement on Saudi Exchange’s Website	2026-05-06 Corresponding to 1447-11-19
Hyperlink to the Previous Announcement on the Saudi Exchange Website	Click Here
Latest Developments Of The Announced Event	The issuance of the non-objection of the General Authority for Competition on the completion of the economic concentration resulting from the Transaction.
Reasons For The Delay on The Date of The Event Previously Announced	N/A
The costs associated with the event, and if they have changed or not with indication of the reasons.	N/A
Delay consequences on the Company’s financial results	N/A
Additional Information	The Company will announce any other material development(s) in due course.